Biomarkers To Prevent Disability In Multiple Sclerosis

Abstract

Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to suboptimal MS management and accumulation of preventable disability. We will use MSBase, the largest international MS cohort, and several international cohorts, to build an algorithm that will enable physicians to identify the best treatment for individual patients with MS at any given time.